Skip to main content
logo
Arovella Therapeutics Limited (ASX:ALA)
Australia flag Australia · Delayed Price · Currency is AUD
0.0700
+0.0020 (2.94%)
Mar 31, 2026, 2:00 PM AEST

Arovella Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-7.93-7.51-8.75-10.18-8.62-5.05
Depreciation & Amortization
0.120.110.040.140.20.2
Other Amortization
---0.690.360.45
Asset Writedown & Restructuring Costs
---1.560.851.25
Stock-Based Compensation
0.840.841.050.870.580.04
Other Operating Activities
0.520.010.10.010.440.02
Change in Accounts Receivable
---0.010.030.50.34
Change in Accounts Payable
-0.6-0.60.580.22-0.27-0.45
Change in Other Net Operating Assets
0.220.220.070.26-0.3-0.34
Operating Cash Flow
-6.82-6.93-6.91-6.4-6.27-3.54
Capital Expenditures
-0.1-0.41-0.13-0-0.04-0.17
Sale of Property, Plant & Equipment
---0.1--
Sale (Purchase) of Intangibles
-----0.53-0.35
Other Investing Activities
-0.02-0.02-0.05---
Investing Cash Flow
-0.12-0.43-0.180.1-0.57-0.51
Long-Term Debt Repaid
----0.07-0.07-0.06
Total Debt Repaid
----0.07-0.07-0.06
Net Debt Issued (Repaid)
----0.07-0.07-0.06
Issuance of Common Stock
15.8916.8114.615.486.2610.58
Other Financing Activities
-1.3-1.29----0.72
Financing Cash Flow
14.5915.5214.615.416.199.8
Foreign Exchange Rate Adjustments
-0.0300.02---
Net Cash Flow
7.628.167.54-0.9-0.655.74
Free Cash Flow
-6.93-7.34-7.04-6.4-6.3-3.71
Free Cash Flow Margin
-215.75%-213.45%-360.80%-439.99%-2130.85%-374.92%
Free Cash Flow Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
Cash Interest Paid
---0.020.180.03
Cash Income Tax Paid
--3.3-1.94-1.05-0.52-1.12
Levered Free Cash Flow
-4.4-4.8-4.42-3.19-4.37-2.2
Unlevered Free Cash Flow
-4.4-4.8-4.42-3.18-4.25-2.19
Change in Working Capital
-0.38-0.380.640.51-0.07-0.46
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.